NALBAT, E. Et Al. 2022. Novel isoxazole- piperazine derivatives inhibit the stemness of HCC cells. AASLD-TASL Digital Hepatology Meeting , (Ankara, Turkey), 5-6.

NALBAT, E., İBİŞ, K., ÇALIŞKAN, B., BANOĞLU, E., ATALAY, M. V., & ATALAY, R., (2022). Novel isoxazole- piperazine derivatives inhibit the stemness of HCC cells . AASLD-TASL Digital Hepatology Meeting (pp.5-6). Ankara, Turkey

NALBAT, ESRA Et Al. "Novel isoxazole- piperazine derivatives inhibit the stemness of HCC cells," AASLD-TASL Digital Hepatology Meeting, Ankara, Turkey, 2022

NALBAT, ESRA Et Al. "Novel isoxazole- piperazine derivatives inhibit the stemness of HCC cells." AASLD-TASL Digital Hepatology Meeting , Ankara, Turkey, pp.5-6, 2022

NALBAT, E. Et Al. (2022) . "Novel isoxazole- piperazine derivatives inhibit the stemness of HCC cells." AASLD-TASL Digital Hepatology Meeting , Ankara, Turkey, pp.5-6.

@conferencepaper{conferencepaper, author={ESRA NALBAT Et Al. }, title={Novel isoxazole- piperazine derivatives inhibit the stemness of HCC cells}, congress name={AASLD-TASL Digital Hepatology Meeting}, city={Ankara}, country={Turkey}, year={2022}, pages={5-6} }